| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-09 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |